Psychedelics, With a Focus on Psilocybin: Issues for the Clinician.
Journal of psychiatric practice September 1, 2023 Amir Garakani, Jeanne L Alexander, Calvin R Sumner et al. 6 citations
Public and clinical interest in psychedelics is growing, with many studies underway for depression, anxiety, PTSD, and substance use disorders. This paper focuses on psilocybin, explaining its mechanism, psychedelic effects, and dosing. It reviews treatment studies, primarily for treatment-resistant depression and cancer-related anxiety, and discusses future directions and potential limitations in studying and regulating psilocybin and other psychedelics.